Genzyme reasonable sized biotech company. And reasonable size revenues for last year. But more importantly to the discussion today is that we truly have a diverse portfolio of marketed therapeutics products and services and we have very broad pipeline interests. And to drill down on that just a l...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
